K Man
Totally agree - I have actually started to think about BIO's prospects in even more simple terms as follows
- I suspect BIO will exceed their revised forecast of $12.5 million for 23/24 and reckon it could well be closer to $13.5 - $14 million
A very much back of the envelope approach to my thinking is as follows
- Assume $13.5 million for 23/24 - that would be an amazing and circa 90% growth on last years (from memory) $7.2 million in sales.
- Take a conservative view and as such assume a diminishing annual sales growth rate and drop 90% back to say 70% for 24/25 - $13.5 sales grows to $23 million
- Drop growth rate again for 25/26 to say 55% - $23 sales grows to $36 million
- Drop growth again for 26/27 to say 40% - $36 sales becomes $51 million
- Drop growth again for 27/28 to say 30% - $51 sales becomes $67 million
So even with a falling annual growth BIO is selling/growing like crazy
The exciting prospect therefore is where this company might be in terms of $$ sales if they maintain high growth levels - simply put if growth diminishes at a slower pace than the examples above.
A hugely exciting few years ahead if BIO keeps executing strategy as they have to date, keep developing great products and keep expanding sales networks both here and overseas - for example the UK market has 76 million people and is 3 times the size of the Australian market - what do things look like if that really grabs and or they start accelerating into European and Asian markets and so on.
It is the compounding potential of annualised % growth to sales volume that is so exciting for mine.
People can play with the annualised % growth numbers above and you will see what I mean
Very happy to be long in this one and holding onto every share I have
DYOR and good luck to all holders
- Forums
- ASX - By Stock
- Ann: FY24 Revenue Guidance Upgrade to $12.5M
K ManTotally agree - I have actually started to think about...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BIO (ASX) to my watchlist
(20min delay)
|
|||||
Last
68.0¢ |
Change
0.015(2.26%) |
Mkt cap ! $149.0M |
Open | High | Low | Value | Volume |
66.5¢ | 69.0¢ | 66.0¢ | $173.2K | 255.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 46226 | 68.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
69.0¢ | 83602 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 44195 | 0.680 |
1 | 1000 | 0.670 |
8 | 41745 | 0.660 |
1 | 16550 | 0.655 |
5 | 27476 | 0.650 |
Price($) | Vol. | No. |
---|---|---|
0.690 | 48000 | 2 |
0.700 | 11170 | 2 |
0.705 | 5839 | 1 |
0.720 | 44230 | 3 |
0.735 | 18000 | 1 |
Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
Featured News
CC9
Chariot Corporation (ASX:CC9) refines Black Mountain strategy, launching Pilot Mine to seize U.S. lithium opportunity
BIO (ASX) Chart |